New Launch Site Discount — 50% off sitewide· +10% with Bank Pay
1 / 6
Myogenic Peptides · Performance & Recovery Research
LL-37
$80.00$40.00Save 50%
99% Pure | Multi Dose | Finished in the USA
LL-37 is a human-derived antimicrobial peptide trusted by labs to model innate-immunity, antimicrobial defense, and wound-healing processes. Each 5 mg vial delivers a ready-to-use peptide that boosts microbial-killing assays, supports cell-migration in scratch-wound models, and activates innate-immune signaling—with no extra compounds or guesswork.
For Research Use Only. Not for human consumption or therapeutic treatment.
99% Pure | Multi Dose | Finished in the USA
LL-37 is a human-derived antimicrobial peptide trusted by labs to model innate-immunity, antimicrobial defense, and wound-healing processes. Each 5 mg vial delivers a ready-to-use peptide that boosts microbial-killing assays, supports cell-migration in scratch-wound models, and activates innate-immune signaling—with no extra compounds or guesswork. HPLC-verified to ≥ 99% purity, and endotoxin-screened (< 0.1 EU/mg), LL-37 gives you crisp, reproducible data every time.
What Is LL-37 Peptide?
LL-37 is a naturally occurring, 37-amino-acid antimicrobial peptide (cathelicidin) that plays a key role in the body’s first line of defense. In research, LL-37 peptide is used to explore microbial killing, wound-closure mechanisms, and innate immune signaling, giving scientists a direct tool to study host-pathogen interactions and tissue repair.
Why Choose LL-37?
Unlike generic antimicrobial reagents, LL-37 combines broad-spectrum bacterial activity with tissue-repair support in one molecule. Its balanced profile—effective against planktonic bacteria and biofilms, yet supportive of keratinocyte/fibroblast migration—makes LL-37 the go-to peptide for integrated infection and healing research.
What Sets LL-37 Apart?
What sets Retatrutide apart from traditional single-pathway compounds like semaglutide is its ability to address multiple metabolic pathways at once, making it highly attractive for advanced obesity, diabetes, and longevity studies.
Research observations
01
Antimicrobial Activity
LL-37 rapidly disrupts bacterial membranes in vitro, making it ideal for quantifying antimicrobial potency.
02
Wound-Healing Modeling
Promotes keratinocyte and fibroblast migration in scratch assays, providing a clear readout of tissue-repair dynamics.
03
Immune-Signaling Insights
Activates Toll-like receptor pathways and cytokine release in macrophage cultures, supporting innate-immunity studies.
04
Biofilm Disruption
Penetrates and breaks down bacterial biofilms in static-culture models, enabling advanced infection-control research.